Literature DB >> 22098533

Comparative study of the in situ immune response in oral and nasal mucosal leishmaniasis.

M R Palmeiro1, F N Morgado, C M Valete-Rosalino, A C Martins, J Moreira, L P Quintella, A de Oliveira Schubach, F Conceição-Silva.   

Abstract

Mucosal Leishmaniasis (ML) may occur in both nasal and oral mucosa. However, despite the impressive tissue destruction, little is known about the oral involvement. To compare some changes underlying inflammation in oral and nasal ML, we performed immunohistochemistry on mucosal tissue of 20 patients with ML (nasal [n = 12]; oral [n = 8] lesions) and 20 healthy donors using antibodies that recognize inflammatory markers (CD3, CD4, CD8, CD22, CD68, neutrophil elastase, CD1a, CLA, Ki67, Bcl-2, NOS2, CD62E, Fas and FasL). A significantly larger number of cells, mainly T cells and macrophages, were observed in lesions than in healthy tissue. In addition, high nitric oxide synthase 2 (NOS2) expression was associated with a reduced detection of parasites, highlighting the importance of NOS2 for parasite elimination. Oral lesions had higher numbers of neutrophils, parasites, proliferating cells and NOS2 than nasal lesions. These findings, together with the shorter duration of oral lesions and more intense symptoms, suggest a more recent inflammatory process. It could be explained by lesion-induced oral cavity changes that lead to eating difficulties and social stigma. In addition, the frequent poor tooth conservation and gingival inflammation tend to amplify tissue destruction and symptoms and may impair and confuse the correct diagnosis, thus delaying the onset of specific treatment.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22098533     DOI: 10.1111/j.1365-3024.2011.01343.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  5 in total

1.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

2.  Oral manifestations in the American tegumentary leishmaniasis.

Authors:  Daniel Cesar Silva da Costa; Mariana Reuter Palmeiro; João Soares Moreira; Ana Cristina da Costa Martins; Aline Fagundes da Silva; Maria de Fátima Madeira; Leonardo Pereira Quintella; Eliame Mouta Confort; Armando de Oliveira Schubach; Fátima da Conceição Silva; Cláudia Maria Valete-Rosalino
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

3.  CD3+CD4negCD8neg (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a+ cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Authors:  Raquel Ferraz; Clarissa F Cunha; Maria Inês F Pimentel; Marcelo R Lyra; Tatiana Pereira-Da-Silva; Armando O Schubach; Alda Maria Da-Cruz; Alvaro Luiz Bertho
Journal:  Parasit Vectors       Date:  2017-05-03       Impact factor: 3.876

Review 4.  The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.

Authors:  Fatima Conceição-Silva; Jessica Leite-Silva; Fernanda N Morgado
Journal:  Front Microbiol       Date:  2018-06-19       Impact factor: 5.640

5.  Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites.

Authors:  Natalia C Rochael; Anderson B Guimarães-Costa; Michelle T C Nascimento; Thiago S DeSouza-Vieira; Matheus P Oliveira; Luiz F Garcia e Souza; Marcus F Oliveira; Elvira M Saraiva
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.